Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Milrinone Lactate

Known as: Lactate, Milrinone, Milrinone Lactate [Chemical/Ingredient] 
A bipyridine agent with positive inotropic and vasodilator properties. Milrinone lactate selectively inhibits fraction III cyclic adenosine… Expand
National Institutes of Health

Related topics

Related topics

8 relations
100 ML Milrinone Lactate 0.2 MG/ML InjectionCongestive heart failureDrug toxicityHypersensitivity
Expand

Broader (1)

Milrinone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Milrinone Pharmacokinetics and Pharmacodynamics in Neonates with Persistent Pulmonary Hypertension of the Newborn
Objective To describe the pharmacokinetics and pharmacodynamics of milrinone in infants with persistent pulmonary hypertension of… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2007
2007
Method of preparing milrinone lactate
The invention discloses a preparation method of lactate milrinone, which belongs to the fields of chemicals and chemical… Expand
2002
2002
Physical compatibility of milrinone lactate injection with intravenous drugs commonly used in the pediatric intensive care unit.
  • M. Veltri, K. Conner
  • American journal of health-system pharmacy : AJHP…
  • 2002
    • Corpus ID: 12525488
 
1999
1999
Stability of milrinone lactate in the presence of 29 critical care drugs and 4 i.v. solutions.
The stability of milrinone lactate in the presence of 29 critical care drugs during simulated Y-site injection and in 4 i.v… Expand
1999
1999
Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure.
OBJECTIVE To assess the hemodynamic and vasodilating effects of milrinone lactate (ML) in patients with dilated cardiomyopathy… Expand
  • table I
  • table II
  • table III
  • figure 1
Highly Cited
1998
Highly Cited
1998
Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock.
OBJECTIVES The objectives of this study were to determine the pharmacokinetics of milrinone lactate in pediatric patients with… Expand
1998
1998
Stability of Milrinone Lactate 200 mcg/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
The stability of milrinone lactate 200 microgram/mL in either 5% dextrose injection or 0.9% sodium chloride injection was studied… Expand
1998
1998
Stability of Milrinone Lactate in 5% Dextrose Injection and 0.9% Sodium Chloride Injection at Concentrations of 400, 600, 800 mcg/mL
Milirone lactate is a phosphodiesterase inhibitor that is used in the acute phase of congestive heart failure. It is available in… Expand
1998
1998
Stability of Milrinone Lactate 200 micrograms/mL in 5% Dextrose Injection and 0.9% Sodium Chloride Injection.
  • F. Wong, M. Gill
  • International journal of pharmaceutical…
  • 1998
    • Corpus ID: 24282570
The stability of milrinone lactate 200 microgram/mL in either 5% dextrose injection or 0.9% sodium chloride injection was studied… Expand
Highly Cited
1996
Highly Cited
1996
Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
STUDY OBJECTIVE To determine the hemodynamic effects of i.v. milrinone lactate in pediatric patients with nonhyperdynamic septic… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE